Dermatomyositis associated with malignant melanoma—A marker of poor prognosis?
- 28 February 2006
- journal article
- case report
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 54 (2), 221-226
- https://doi.org/10.1016/j.jaad.2005.10.026
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Final Version of the American Joint Committee on Cancer Staging System for Cutaneous MelanomaJournal of Clinical Oncology, 2001
- Diffuse melanosis arising from metastatic melanoma: Pathogenetic function of elevated melanocyte peptide growth factorsJournal of the American Academy of Dermatology, 2001
- Dermatomyositis and metastatic malignant melanoma, with complete regression of the primary lesionBritish Journal of Dermatology, 1994
- Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC protocol 18781)European Journal Of Cancer, 1993
- Prolonged survival in metastatic malignant melanoma associated with vitiligoClinical and Experimental Dermatology, 1991
- Paraneoplastic syndromes, tumor markers, and other unusual features of malignant melanomaJournal of the American Academy of Dermatology, 1986
- Vitiligo in patients with metastatic melanoma: A good prognostic signJournal of the American Academy of Dermatology, 1983
- Dermatomyositis associated with malignant melanoma. Parallel occurrence, remission, and relapse of the two processes in a patientCancer, 1983
- Polymyositis and DermatomyositisNew England Journal of Medicine, 1975
- Dermatomyositis and Malignant Neoplasms in AdultsArchives of Dermatology, 1960